10 completed, 9 unknown, 5 recruiting, 1 not yet recruiting. 10 Phase 2, 8 Phase 3, 6 Phase 4, 4 Not applicable, 1 Early Phase 1.
Follow Atorvastatin 20mg: new trials by email Literature Review of Atorvastatin 20mg trials Research Report on Atorvastatin 20mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation Atorvastatin 20mg - Cerebrovascular Event, Stent Stenosis | Phase 4 | Recruiting | Duan Chuanzhi | 354 | 2024-07-30 | 2026-03-03 |
| Prophylactic Treatment With Atorvastatin for Episodic Migraine. Atorvastatin 40mg, Placebo, Atorvastatin 20mg - Episodic Migraine | Phase 2 | Recruiting | St. Olavs Hospital | 450 | 2024-05-01 | 2026-07-14 |
| Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma Atorvastatin 20mg - Glioblastoma, IDH-wildtype | Phase 2 | Recruiting | Tianjin Medical University General Hospital | 50 | 2024-04-01 | 2024-03-25 |
| ATORvastatin in Pulmonary TUBerculosis Atorvastatin 20mg, Atorvastatin 40mg, Atorvastatin 60mg - Pulmonary Tuberculosis, Tuberculosis | Phase 2 | Recruiting | Obafemi Awolowo University Teaching Hospital | 440 | 2024-01-03 | 2025-09-25 |
| A Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study Atorvastatin 20mg, Placebo - Graves' Orbitopathy | Phase 3 | Not yet recruiting | University of Pisa | 102 | 2024-01-01 | 2023-03-15 |
| High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients Atorvastatin 80mg, Atorvastatin 20mg - Mechanical Thrombectomy, Acute Ischemic Stroke | Phase 4 | Unknown | Zhongda Hospital | 162 | 2023-07-01 | 2023-06-23 |
| Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk Atorvastatin 20mg, Placebo - Liver Fibroses, Cirrhosis | Phase 2 | Recruiting | Raymond Chung | 60 | 2023-05-10 | 2026-10-07 |
| Allopurinol Versus Atorvastatin to Prevent Complications of Liver Cirrhosis Allopurinol 300 MG, Atorvastatin 20mg, Placebo - Cirrhosis, Hepatic Encephalopathy | Phase 2 / Phase 3 | Completed | Tanta University | 150 | 2022-11-15 | 2026-08-11 |
| Statin Impact on Hepatic Decompensation Atorvastatin 20mg, Placebo - Quality of Life, the Incidence of Whole Complications Resultant From Decompensated Liver | Phase 2 / Phase 3 | Completed | Tanta University | 100 | 2022-06-15 | 2026-09-14 |
| Atorvastatin in Management of Newly Diagnosed ITP Atorvastatin 20mg, Atorvastatin 10mg, Dexamethasone - Immune Thrombocytopenia, Purpura, Thrombocytopenic | Phase 2 / Phase 3 | Unknown | Shandong University | 30 | 2021-11-01 | 2021-09-05 |
| Atorvastatin in the TREATment of Intracranial Unruptured VertebroBasilar Dissecting Aneurysms Atorvastatin 20mg - Dissecting Aneurysm of Cerebral Artery, Intramural Hematomas | Not applicable | Unknown | Beijing Neurosurgical Institute | 40 | 2021-07-01 | 2022-04-06 |
| Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19 intermediate dose Enoxaparin/ unfractionated heparin, standard prophylactic dose Enoxaparin/ unfractionated heparin, Atorvastatin 20mg - Covid19 | Phase 3 | Completed | Rajaie Cardiovascular Medical and Research Center | 600 | 2020-07-30 | 2021-08-17 |
| Efficacy of Atorvastatin in Chronic Subdural Haematoma Atorvastatin 20mg, Placebos - Chronic Subdural Hematoma | Phase 3 | Unknown | Chinese University of Hong Kong | 690 | 2020-01-09 | 2021-11-22 |
| Effect of Atorvastatin on 5-Fluorouracil Induced Mucositis Atorvastatin 20mg - Colorectal Cancer | Not applicable | Unknown | Ain Shams University | 100 | 2019-10-01 | 2019-11-05 |
| 7-day Atorvastatin and Emotional Processing Atorvastatin 20mg, Lactose placebo - Healthy | Not applicable | Completed | University of Oxford | 50 | 2019-06-19 | 2020-12-01 |
| Atorvastatin ± Aspirin in Lynch Syndrome Syndrome Atorvastatin 20mg, Atorvastatin 20mg AND Aspirin 325 mg - Lynch Syndrome | Early Phase 1 | Completed | Fox Chase Cancer Center | 43 | 2018-09-10 | 2025-08-07 |
| To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors Atorvastatin 20mg, Atorvastatin 20 mg + CKD-519 50 mg, Atorvastatin 20 mg + CKD-519 100 mg - Dyslipidemias | Phase 2 | Completed | Chong Kun Dang Pharmaceutical | 62 | 2017-03-23 | 2018-11-06 |
| Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C Bempedoic acid 180mg, Ezetimibe 10mg, Atorvastatin 20mg - Hypercholesterolemia | Phase 2 | Completed | Esperion Therapeutics, Inc. | 63 | 2017-01-19 | 2020-04-03 |
| STATIN: Web-based Investigation of Side Effects Atorvastatin 20mg, Placebo - Cardiovascular Disease | Phase 4 | Completed | London School of Hygiene and Tropical Medicine | 200 | 2016-09-01 | 2019-08-16 |
| Phase 3 Study to Evaluate the Efficacy and Safety of Omega-3-acids Ethylesters 90 in Type Ⅱb Hyperlipidemia Atorvastatin 20mg, Omega-3-acids ethylesters 90 4g, Placebo(Omega-3-acids ethylesters 90) - Hyperlipidemia, Familial Combined | Phase 3 | Unknown | Kuhnil Pharmaceutical Co., Ltd. | 80 | 2014-01-01 | 2014-03-20 |
Showing 20 of 26. Sign in to see all of them.
Fibrosis (2) · Hypercholesterolemia (2) · Hyperlipidemias (2) · Hyperlipoproteinemia Type II (2) · Ischemic Stroke (2) · Ascites (1) · Atherosclerosis (1) · Brain Death (1) · COVID-19 (1) · Cardiovascular Diseases (1) · Colorectal Neoplasms (1) · Colorectal Neoplasms, Hereditary Nonpolyposis (1) · Coronary Artery Disease (1) · Diabetes Mellitus (1) · Dyslipidemias (1)
Chong Kun Dang Pharmaceutical (2) · Tanta University (2) · Ain Shams University (1) · Asan Medical Center (1) · Beijing Neurosurgical Institute (1) · Chinese University of Hong Kong (1) · Duan Chuanzhi (1) · Esperion Therapeutics, Inc. (1) · Fox Chase Cancer Center (1) · Kuhnil Pharmaceutical Co., Ltd. (1) · London School of Hygiene and Tropical Medicine (1) · Obafemi Awolowo University Teaching Hospital (1) · Rajaie Cardiovascular Medical and Research Center (1) · Raymond Chung (1) · Sang Hak Lee (1)
South Korea (6) · China (5) · United States (4) · Egypt (3) · United Kingdom (2) · Australia (1) · Hong Kong (1) · Iran (1) · Italy (1) · Nigeria (1) · Norway (1)
Anne H Aamodt, Senior researcher (1) · Behnood Bikdeli, MD, MS (1) · Bendik S Winsvold, Post.doc. (1) · Bolanle A Omotoso, MD (1) · Choung-Soo Kim, MD (1) · Chuanzhi Duan, MD (1) · Chunsheng Kang (1) · Gao-Jun Teng, M.D. (1) · Hai-Peng Wang, M.D. (1) · Haleema Shakur, RN (1) · Hee Kyoung Cheon, Ph.D. (1) · Hong Seog Seo, Ph.D. (1) · Kiyuk Chang, M.D. (1) · Kjersti G Vetvik, Ph.d. (1)
PMID 10634801, PMID 11498461, PMID 15247520, PMID 17520105, PMID 18650989, PMID 18996523, PMID 19081418, PMID 19195513, PMID 20110022, PMID 20816118, PMID 20934572, PMID 22472556, PMID 22592524, PMID 23728830, PMID 24462073, PMID 25355814, PMID 26590269, PMID 29146831, PMID 29327999, PMID 29968431, PMID 30565953, PMID 31352800, PMID 31504418, PMID 32992075, PMID 33447904, PMID 33627334, PMID 33734299, PMID 34991791, PMID 34996756, PMID 35165110, PMID 35244208, PMID 35292570, PMID 35487525, PMID 36375835, PMID 36700744, PMID 36944357, PMID 37324979, PMID 38198155, PMID 38719444, PMID 41432563, PMID 41865069